Pui Ying Chan
- Biotechnology top 10%
- Cancer Research and Treatments 5
- Ophthalmology top 5%
- Ocular Oncology and Treatments 5
-
- Cancer Immunotherapy and Biomarkers 2
- Cancer Cells and Metastasis 2
- Pancreatic and Hepatic Oncology Research 1
-
- Immunotherapy and Immune Responses 2
-
- Ubiquitin and proteasome pathways 2
-
- Neuroblastoma Research and Treatments 2
- Co-authors
- Peter W. SzlosarekEdurne ArriolaMatthew WheaterChristian H. OttensmeierIoannis KarydisGordon HayVictoria M.L. CohenPeter E. Hall
- Journals
- The Lancet (1 paper)Journal of Clinical Oncology (4 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United KingdomUnited StatesIreland
In The Last Decade
Pui Ying Chan
10 papers receiving 283 citations
Peers
Comparison fields: 5 of 39
- Biotechnology 80
- Ophthalmology 72
- Cancer Research 81
- Oncology 124
- Immunology 64
Countries citing papers authored by Pui Ying Chan
This map shows the geographic impact of Pui Ying Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pui Ying Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pui Ying Chan more than expected).
Fields of papers citing papers by Pui Ying Chan
This network shows the impact of papers produced by Pui Ying Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pui Ying Chan. The network helps show where Pui Ying Chan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pui Ying Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 21 | |
| 4 | 2021 | 14 | |
| 5 | 2018 | 0 | |
| 6 | 2017 | 54 | |
| 7 | 2017 | 32 | |
| 8 | 2017 | 89 | |
| 9 | 2016 | 64 | |
| 10 | 2016 | 2 | |
| 11 | 2015 | 1 | |
| 12 | 2011 | 0 |
About Pui Ying Chan
Pui Ying Chan is a scholar working on Biotechnology, Ophthalmology and Oncology, having authored 12 papers that have together received 283 indexed citations. Recurring topics across this work include Cancer Research and Treatments (5 papers), Ocular Oncology and Treatments (5 papers), Ubiquitin and proteasome pathways (2 papers), Immunotherapy and Immune Responses (2 papers), Neuroblastoma Research and Treatments (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Cells and Metastasis (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Biotechnology (80 citations), Ophthalmology (72 citations) and Cancer Research (81 citations). Pui Ying Chan has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Peter W. Szlosarek, Edurne Arriola, Matthew Wheater, Christian H. Ottensmeier, Ioannis Karydis, Gordon Hay, Victoria M.L. Cohen, Peter E. Hall, Xiaoxing Feng and John S. Bomalaski. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.